CB1 receptors mediate rimonabant-induced pruritic responses in mice: Investigation of locus of action

Psychopharmacology

Volumn 216, Issue 3, 2011, Pages 323-331

  Schlosburg, Joel E ^a   O'Neal, Scott T ^a   Conrad, Daniel H ^a   Lichtman, Aron H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cannabinoid; CB1; Compound 48 80; Intracerebroventricular; Intrathecal; Itch; Mast cell; Pruritus; Rimonabant; Scratching

Indexed keywords

CANNABINOID 1 RECEPTOR; LORATADINE; RIMONABANT; HISTAMINE H1 RECEPTOR ANTAGONIST; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; TETRAHYDROCANNABINOL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; HYPERSENSITIVITY; IMMOBILIZATION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MALE; MAST CELL; MOUSE; NEUROMODULATION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PRURITUS; SCRATCHING; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; MOUSE MUTANT; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HISTAMINE H1 ANTAGONISTS; HYPERSENSITIVITY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; INJECTIONS, SUBCUTANEOUS; LORATADINE; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PAIN; PIPERIDINES; PRURITUS; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL;

EID: 79961173862     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2224-5     Document Type: Article

References (46)

1. MR Allansmith RS Baird RN Ross NP Barney KJ Bloch 1987 Effect of multiple applications of compound 48/80 on mast cells of rat conjunctiva Acta Ophthalmol Copenh 65 406 412 3661142 10.1111/j.1755-3768.1987.tb07015.x 1:CAS:528:DyaL1cXpt12itA%3D%3D (Pubitemid 17147480)
2. LC Ambrus L Thurber 1975 Effect of cromolyn sodium and of daily exposure to compound 48/80 on experimental asthma Res Commun Chem Pathol Pharmacol 11 491 494 239445 1:CAS:528:DyaE2MXlsVWqsrY%3D
3. D Andrew AD Craig 2001 Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch Nat Neurosci 4 72 77 11135647 10.1038/82924 1:CAS:528:DC%2BD3MXitVegug%3D%3D (Pubitemid 32095528)
4. AR Best WG Regehr 2008 Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses J Neurosci 28 6508 6515 18562622 10.1523/JNEUROSCI.0678-08.2008 1:CAS:528:DC%2BD1cXotVegtLg%3D
5. Cevikbas F, Steinhoff M, Ikoma A (2010) Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development. CNS Neurosci Ther (in press)
6. SA Cook JA Lowe BR Martin 1998 CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol J Pharmacol Exp Ther 285 1150 1156 9618417 1:CAS:528:DyaK1cXjvFCqt7Y%3D (Pubitemid 28277913)
7. NA Darmani 2001 Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice Pharmacol Biochem Behav 68 311 317 11267636 10.1016/S0091-3057(00)00477-9 1:CAS:528:DC%2BD3MXitVOmu7k%3D (Pubitemid 32231193)
8. NA Darmani DK Pandya 2000 Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice J Neural Transm 107 931 945 11041273 10.1007/s007020070043 1:CAS:528:DC%2BD3cXntlygtro%3D
9. NA Darmani JJ Janoyan N Kumar JL Crim 2003 Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover Pharmacol Biochem Behav 75 777 787 12957219 10.1016/S0091-3057(03)00150-3 1:CAS:528:DC%2BD3sXmvV2ru70%3D (Pubitemid 37289462)
10. M Dvorak A Watkinson F McGlone R Rukwied 2003 Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin Inflamm Res 52 238 245 12835895 1:CAS:528:DC%2BD3sXls1WlsLk%3D (Pubitemid 36791930)
11. European Medicines Agency (2008) Accomplia: European public assessment reports. European Medicines Agency, London
12. AG Fitton RG Pertwee 1982 Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol Br J Pharmacol 75 409 414 6313110 1:CAS:528:DyaL38XitFSkt7c%3D (Pubitemid 12213571)
13. M Granberg CJ Fowler SO Jacobsson 2001 Effects of the cannabimimetic fatty acid derivatives 2-arachidonoylglycerol, anandamide, palmitoylethanolamide and methanandamide upon IgE-dependent antigen-induced beta-hexosaminidase, serotonin and TNF alpha release from rat RBL-2 H3 basophilic leukaemic cells Naunyn-Schmiedebergs Arch Pharmacol 364 66 73 11485041 10.1007/s002100100424 1:CAS:528:DC%2BD3MXktFWgtrg%3D (Pubitemid 32646343)
14. VL Haller DL Stevens SP Welch 2008 Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase Eur J Pharmacol 600 50 58 18762181 10.1016/j.ejphar.2008.08.005 1:CAS:528:DC%2BD1cXhtlyltLvN
15. JL Hylden GL Wilcox 1983 Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level J Pharmacol Exp Ther 226 398 404 6192235 1:CAS:528:DyaL3sXltFKksrc%3D (Pubitemid 13041514)
16. N Inagaki K Igeta JF Kim M Nagao N Shiraishi N Nakamura H Nagai 2002 Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80 Eur J Pharmacol 448 175 183 12144939 10.1016/S0014-2999(02)01933-7 1:CAS:528:DC%2BD38Xls1WrsLo%3D (Pubitemid 34874585)
17. JJ Janoyan JL Crim NA Darmani 2002 Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids Pharmacol Biochem Behav 71 155 162 11812518 10.1016/S0091-3057(01) 00647-5 1:CAS:528:DC%2BD38Xms1Kiuw%3D%3D (Pubitemid 34102474)
18. TU Jarbe BJ LeMay T Olszewska VK Vemuri JT Wood A Makriyannis 2008 Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats Pharmacol Biochem Behav 91 84 90 18640150 10.1016/j.pbb.2008.06.014 1:STN:280:DC%2BD1crot1elsg%3D%3D
19. M Karsak E Gaffal R Date L Wang-Eckhardt J Rehnelt S Petrosino K Starowicz R Steuder E Schlicker B Cravatt R Mechoulam R Buettner S Werner V Di Marzo T Tuting A Zimmer 2007 Attenuation of allergic contact dermatitis through the endocannabinoid system Science 316 1494 1497 17556587 10.1126/science. 1142265 1:CAS:528:DC%2BD2sXmtFSjtrs%3D (Pubitemid 46906619)
20. S Kelly LF Donaldson 2008 Peripheral cannabinoid CB1 receptors inhibit evoked responses of nociceptive neurones in vivo Eur J Pharmacol 586 160 163 18410918 10.1016/j.ejphar.2008.03.003 1:CAS:528:DC%2BD1cXmsVGmtrY%3D
21. RS Landsman TH Burkey P Consroe WR Roeske HI Yamamura 1997 SR141716A is an inverse agonist at the human cannabinoid CB1 receptor Eur J Pharmacol 334 R1 R2 9346339 10.1016/S0014-2999(97)01160-6 1:CAS:528:DyaK2sXmsVKmsL4%3D (Pubitemid 27417820)
22. D Moranta S Esteban JA Garcia-Sevilla 2009 Chronic treatment and withdrawal of the cannabinoid agonist WIN 55, 212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain Naunyn Schmiedebergs Arch Pharmacol 379 61 72 18709357 10.1007/s00210-008-0337-0 1:CAS:528:DC%2BD1MXhtlOjsb0%3D
23. H Ohtsuki K Takeuchi S Okabe 1985 Effects of prolonged treatment with compound 48/80 on the gastric mucosa and mast cells in the rat Jpn J Pharmacol 38 195 198 4032856 10.1254/jjp.38.195 1:CAS:528:DyaL2MXksVyit7o%3D (Pubitemid 15091072)
24. NW Pedigo WL Dewey LS Harris 1975 Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice J Pharmacol Exp Ther 193 845 852 1151733 1:CAS:528:DyaE2MXkslahtbw%3D
25. JD Richardson S Kilo KM Hargreaves 1998 Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors Pain 75 111 119 9539680 10.1016/S0304-3959(97)00213-3 1:CAS:528:DyaK1cXotlWjtg%3D%3D (Pubitemid 28254862)
26. M Rinaldi-Carmona F Barth M Heaulme D Shire B Calandra C Congy S Martinez J Maruani G Neliat D Caput 1994 SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett 350 240 244 8070571 10.1016/0014-5793(94)00773-X 1:CAS:528:DyaK2cXmsVKjsrw%3D (Pubitemid 24268029)
27. T Rubino D Vigano E Zagato M Sala D Parolaro 2000 In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments Synapse 35 8 14 10579803 10.1002/(SICI)1098-2396(200001)35:1<8::AID-SYN2>3.0.CO;2-Y 1:CAS:528:DyaK1MXnvF2hur0%3D
28. M Rutkowska H Gliniak 2009 The influence of ACEA-a selective cannabinoid CB1 receptor agonist on whole blood and platelet-poor plasma serotonin concentrations Pharmazie 64 598 601 19827303 1:CAS:528:DC%2BD1MXhtlSjsL7M
29. JE Schlosburg DL Boger BF Cravatt AH Lichtman 2009 Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus J Pharmacol Exp Ther 329 314 323 19168707 10.1124/jpet.108.150136 1:CAS:528:DC%2BD1MXksVKmsr0%3D
30. WT Schmeling MJ Hosko 1980 Effect of delta 9-tetrahydrocannabinol on hypothalamic thermosensitive units Brain Res 187 431 442 6245751 10.1016/0006-8993(80)90213-9 1:CAS:528:DyaL3cXktVSlt70%3D (Pubitemid 10094017)
31. M Seyrek S Kahraman MS Deveci O Yesilyurt A Dogrul 2010 Systemic cannabinoids produce CB-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT and 5-HT(2A) receptors Eur J Pharmacol 649 183 194 20868676 10.1016/j.ejphar.2010.09.039 1:CAS:528: DC%2BC3cXhtlKktbzJ
32. LJ Sim-Selley LK Brunk DE Selley 2001 Inhibitory effects of SR141716A on G-protein activation in rat brain Eur J Pharmacol 414 135 143 11239913 10.1016/S0014-2999(01)00784-1 1:CAS:528:DC%2BD3MXhs1Ciurk%3D (Pubitemid 32181880)
33. Y Sugimoto K Umakoshi N Nojiri C Kamei 1998 Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice Eur J Pharmacol 351 1 5 9698198 10.1016/S0014-2999(98)00288-X 1:CAS:528: DyaK1cXktlWrs7w%3D (Pubitemid 28300296)
34. YG Sun ZQ Zhao XL Meng J Yin XY Liu ZF Chen 2009 Cellular basis of itch sensation Science 325 1531 1534 19661382 10.1126/science.1174868 1:CAS:528:DC%2BD1MXhtFanurrN
35. AJ Tallett JE Blundell RJ Rodgers 2007 Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats Psychopharmacol Berl 195 27 39 10.1007/s00213-007-0880-2 1:CAS:528:DC%2BD2sXhtFKitrzK (Pubitemid 47568626)
36. ET Tzavara RJ Davis KW Perry X Li C Salhoff FP Bymaster JM Witkin GG Nomikos 2003 The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions Br J Pharmacol 138 544 553 12598408 10.1038/sj.bjp. 0705100 1:CAS:528:DC%2BD3sXitlCksb8%3D (Pubitemid 36315302)
37. FJ Vaccarino HO Pettit FE Bloom GF Koob 1985 Effects of intracerebroventricular administration of methyl naloxonium chloride on heroin self-administration in the rat Pharmacol Biochem Behav 23 495 498 4048243 10.1016/0091-3057(85)90027-9 1:CAS:528:DyaL2MXlsFCjsLo%3D (Pubitemid 16256922)
38. SP Vickers LJ Webster A Wyatt CT Dourish GA Kennett 2003 Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats Psychopharmacol Berl 167 103 111 1:CAS:528:DC%2BD3sXislyqsbg%3D (Pubitemid 36535298)
39. T Wada K Ishiwata H Koseki T Ishikura T Ugajin N Ohnuma K Obata R Ishikawa S Yoshikawa K Mukai Y Kawano Y Minegishi H Yokozeki N Watanabe H Karasuyama 2010 Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks J Clin Invest 120 2867 2875 20664169 10.1172/JCI42680 1:CAS:528:DC%2BC3cXhtVaiur%2FO
40. L Ward E Wright SB McMahon 1996 A comparison of the effects of noxious and innocuous counterstimuli on experimentally induced itch and pain Pain 64 129 138 8867255 10.1016/0304-3959(95)00080-1 1:STN:280:DyaK2s%2FitVyqtw%3D%3D (Pubitemid 26062250)
41. SJ Ward TW Lefever SM Rawls GT Whiteside EA Walker 2009 Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats Psychopharmacol Berl 206 155 165 10.1007/s00213-009-1592-6 1:CAS:528:DC%2BD1MXpvV2ntbk%3D
42. SP Welch JW Huffman J Lowe 1998 Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A J Pharmacol Exp Ther 286 1301 1308 9732392 1:CAS:528:DyaK1cXmt1Gqs78%3D (Pubitemid 29135543)
43. M Yamazaki T Tsujimura E Morii K Isozaki H Onoue S Nomura Y Kitamura 1994 C-kit gene is expressed by skin mast cells in embryos but not in puppies of Wsh/Wsh mice: age-dependent abolishment of c-kit gene expression Blood 83 3509 3516 7515715 1:CAS:528:DyaK2MXhslKmtg%3D%3D
44. G Yosipovitch MI Duque K Fast AG Dawn RC Coghill 2007 Scratching and noxious heat stimuli inhibit itch in humans: a psychophysical study Br J Dermatol 156 629 634 17263822 10.1111/j.1365-2133.2006.07711.x 1:STN:280:DC%2BD2s3nvFOgug%3D%3D (Pubitemid 46452344)
45. G Yosipovitch K Fast JD Bernhard 2005 Noxious heat and scratching decrease histamine-induced itch and skin blood flow J Investig Dermatol 125 1268 1272 16354198 10.1111/j.0022-202X.2005.23942.x 1:CAS:528:DC%2BD28XjvFOjsg%3D%3D
46. G Zhang W Chen L Lao JC Marvizon 2010 Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization Eur J Neurosci 31 225 237 20074214 10.1111/j.1460-9568.2009.07075.x 1:CAS:528:DC%2BC3cXhtVWqsL7I